Luminescent Analysis of Blood Serum for Diagnostics of Pathological and Pre-Pathological States of Cancer Patients

dc.contributor.authorBondarenko, Marina
dc.contributor.authorZaytseva, Olga
dc.contributor.authorTrusova, Valeriya
dc.contributor.authorMoiseenko, Anton
dc.contributor.authorRukin, Aleksey
dc.contributor.authorUtytskykh, Tetyana
dc.contributor.authorMorozova, Oksana
dc.date.accessioned2021-09-24T06:20:36Z
dc.date.available2021-09-24T06:20:36Z
dc.date.issued2021-07
dc.description.abstractThis study is devoted to the development of a methodological approach to mathematical analysis and data interpretation of blood serum phosphorescence intensity in cancer patients for determining the pathological states and differential diagnostics of oncological process stages. The purpose of the study is blood serum phosphorescence research in patients with colorectal cancer (CRC) and stomach adenocarcinoma (SAC) and determination of the ultraweak luminescence role for diagnostics of the disease, determining its stages, control of pathogenetic therapy efficiency and forecast of recovery. The values of phosphorescence intensity of blood serum films in patients with CRC and SAC are significantly higher than the corresponding values for the control group. Contrary to the absolute intensity, the relative intensity increase compared to the control group is much more informative for oncoprocess diagnostics, since it exhibits three times increase even at the first stage of tumoral process. Serum phosphorescence intensity continues to increase with progressing of the disease. As the result of our study, the relative intensity increase compared to the first stage can be recommended as an informative indicator for differential diagnostics of oncological process stages. As a conclusion, determination of blood serum phosphorescence intensity can be considered as a sensitive and specific diagnostic method in oncology. With a correct methodological approach to data processing and interpretation, this method can be used in clinical practice for determining the oncopathological states, differential diagnostics of oncoprocess stages and diagnostics of precancer changes, which precede tumoral process development.en_US
dc.identifier.citationLuminescent Analysis of Blood Serum for Diagnostics of Pathological and Pre-Pathological States of Cancer Patients / M. Bondarenko, O. Zaytseva, V. Trusova, A. Moiseenko, A. Rukin, T. Utytskykh, O. Morozova // Journal of Fluorescence. – 2021. – Vol. 31. – P. 1065–1073.en_US
dc.identifier.otherhttps://doi.org/10.1007/s10895-021-02744-x
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/29328
dc.language.isoenen_US
dc.subjectoncoprocessen_US
dc.subjectblood serum phosphorescence Ren_US
dc.subjectrelative intensityen_US
dc.subjectmathematical analysisen_US
dc.subjectmethodological approachen_US
dc.subjectdifferential diagnosticsen_US
dc.subjectcancer stagesen_US
dc.titleLuminescent Analysis of Blood Serum for Diagnostics of Pathological and Pre-Pathological States of Cancer Patientsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Luminescent_Analysis_of_Blood_Serum_for_Diagnostic.pdf
Size:
502.89 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
11.22 KB
Format:
Item-specific license agreed upon to submission
Description: